Health Research — Map of Content
Personal health research vault. Cross-referenced notes covering iron metabolism, neurodevelopment, mineral interactions, gut-brain axis, and clinical management.
Patient: Anthony G. | Age: 37 | Key conditions: AuDHD (ADHD-PI + Autism), Trichotillomania, HFE C282Y/H63D compound heterozygote
Lab: Blood Results - March 2026 | Blood Results - December 2025
Genetics: HFE Compound Heterozygosity | HFE Compound Het - Disease Associations Beyond Iron | Genetic Architecture of AuDHD
Iron: Transferrin Saturation - Clinical Significance | Iron Overload and NTBI | Tryptophan-Kynurenine Pathway | Ferroptosis
Neuro: Iron-Dopamine-ADHD Axis | Trichotillomania and Neurodevelopmental Links | Late-Diagnosed Autism - Distinct Profile | Interoception
Sleep: Sleep-HFE Interactions | Sleep Protocols
Clinical: Action Items and Monitoring Plan | Diet and Supplement Strategy | Dietary Management - Iron Overload
Tracking: research/Research Avenues Tracker | UK Testing Guide
Lab Results
- Blood Results - December 2025 — comprehensive health assessment: ferritin 738, low folate, thyroid/HbA1c normal, RHR 88bpm, body composition
- Blood Results - March 2026 — iron studies + minerals: TSAT 60%, ferritin 380 (↓48%), low-normal copper/zinc, HFE confirmed
Genetics
- HFE Compound Heterozygosity — genotype analysis, penetrance data, emerging research
- HFE Compound Het - Disease Associations Beyond Iron — full disease association map: HCC (HR 5.25), colorectal cancer, arthritis, ALS, PCT, diabetes, QoL
- Genetic Architecture of AuDHD — shared genetics across ADHD, autism, TTM, iron; COMT, MTHFR, dopamine/serotonin genes, pharmacogenomics, GWAS overlap, pathway convergence
Iron Metabolism
- Transferrin Saturation - Clinical Significance — TSAT 60%, NTBI thresholds, guidelines
- Iron Overload and NTBI — non-transferrin bound iron, toxicity mechanisms
- Ceruloplasmin and Ferroxidase Activity — copper-iron export axis
- Tryptophan-Kynurenine Pathway — iron-driven inflammation → serotonin depletion → glutamate excitotoxicity
- research/Hepcidin and Brain Iron Regulation — astrocyte-derived hepcidin, BBB iron gating
- research/NTBI in the Brain — NTBI crossing BBB, CSF iron handling
- research/Ferroptosis and Neuronal Iron — iron-dependent cell death, GPX4/System Xc-
- research/Iron Chelation Therapy - Deferiprone — brain-penetrant chelator, neuroprotective studies
Neurodevelopment
- Iron-Dopamine-ADHD Axis — tyrosine hydroxylase, brain iron, HFE + ADHD intersection
- HFE Variants and Brain Iron — C282Y/H63D effects on CNS iron distribution
- Elvanse and Mineral Metabolism — lisdexamfetamine, appetite, mineral monitoring
- Late-Diagnosed Autism - Distinct Profile — biologically distinct subtype, AuDHD, masking, stimulant-mediated unmasking
- ADHD-PI and Internal Hyperactivity — predominantly inattentive ADHD with internal mental hyperactivity, CDS overlap
- Trichotillomania and Neurodevelopmental Links — BFRBs in AuDHD, dopamine-glutamate convergence, iron links, NAC evidence
- research/Iron and Myelination — oligodendrocyte iron dependency, white matter deficits
- research/Iron and Oxidative Stress in Autism — glutathione depletion, Nrf2 dysfunction
- research/Iron and GABAergic Function — GABA/glutamate E/I balance
- research/Iron Glutamate and Excitotoxicity — System Xc-, glutamate release, NAC mechanism
- research/Iron and OCD-Spectrum Repetitive Behaviours — basal ganglia iron in OCD, TTM links
Gut-Brain Axis
- Gut-Brain Axis and Neurodevelopment — microbiome in autism/ADHD, iron-gut dysbiosis, serotonin, vagus nerve, probiotics
Minerals
- Copper-Zinc-Iron Interactions — competitive absorption, DBH, the vicious cycle
- research/Copper-Iron-Dopamine Triangle — catecholamine cascade, TH/DBH/ceruloplasmin triad
- research/Zinc-Iron Brain Competition — ZIP/ZnT transporters, synaptic zinc, NMDA modulation
Sleep
- research/Iron and Circadian Rhythm — IRP1/IRP2, clock genes, sleep disruption
- research/Poor Sleep and AuDHD-HFE Interactions — sleep as central amplifier: ferroptosis, glymphatic failure, gut dysbiosis, executive dysfunction, sensory amplification, dopamine, TTM
- research/Sleep Intervention Protocols for AuDHD Adults — melatonin dosing, adapted CBT-I/ACT-i, chronotherapy, sensory environment, Elvanse timing, magnesium, staged protocol
Body Systems
- neurodevelopment/Interoception in AuDHD - Research Review — interoceptive accuracy, alexithymia, BFRB urge detection, emotional dysregulation, burnout, hunger/satiety under Elvanse, iron-insula link
- research/Autonomic Nervous System and Vagal Tone in AuDHD — HRV, polyvagal theory, vagus-gut-brain axis, sensory reactivity, HRV biofeedback, stimulant effects
- research/Endocrine Effects of HFE Iron Overload — hypogonadism, thyroid, insulin resistance, ferritin-testosterone correlation, phlebotomy recovery window
Exercise
- research/Exercise as Medicine for AuDHD-HFE — executive function, dopamine/BDNF, iron metabolism (hepcidin), sleep, gut microbiome, TTM, practical barriers and prescription
Neuroprotection
- research/HFE and Long-Term Neurodegeneration Risk — Parkinson's/ALS/Alzheimer's meta-analyses, brain QSM imaging, neuroprotective strategy, deferiprone failure, intervention window
- research/NAC and Iron Metabolism — chelation properties, GSH restoration, NTBI reduction, ferroptosis protection, safety in iron overload, thalassemia RCT data
Symptoms
- Fatigue and Burnout — multifactorial drivers, autistic burnout, oxidative stress, endocrine disruption
- Arthropathy and Back Pain — HH arthropathy, lumbar involvement, imaging
Practical Management
- Dietary Management - Iron Overload — inhibitors, enhancers, meal strategy
- Diet and Supplement Strategy — current stack review, NAC, vitamin D, probiotics, inositol, treatment hierarchy
- Action Items and Monitoring Plan — GP script, phlebotomy, investigations, tracking
- research/UK Testing Guide - Pharmacogenomics and Endocrine — best-value UK tests: myDNA (£170), Body Fabulous methylation (£289), Medichecks endocrine (£249)
Research Meta
- research/Research Avenues Tracker — living tracker of promising research leads with evidence ratings
Key Findings from PubMed Verification (March 2026)
The following findings were verified against PubMed and OpenAlex on 2026-03-22, confirming their citations exist and conclusions are accurately represented:
- Chang 2014 (HFE iron overload mice): Iron overload in HFE-model mice produces repetitive behaviour and dopamine disruption in the basal ganglia, providing direct mechanistic evidence that excess brain iron drives stereotyped behaviours relevant to trichotillomania
- Grotzinger 2025 (cross-disorder GWAS): Mapping genetic architecture across 14 psychiatric disorders (n=1,056,201 cases) identified five genomic factors explaining ~66% of genetic variance and 238 pleiotropic loci — ADHD and autism load onto shared factors, with shared signal enriched in excitatory neurons. See Genetic Architecture of AuDHD
- Iron overload causes gut dysbiosis AND cognitive impairment (PMID 39438708): Suparan et al. demonstrated that iron overload causes cognitive impairment via the gut-brain axis, with association between gut/blood microbiome alterations, cognition, and iron burden. See Gut-Brain Axis and Neurodevelopment
- Jiang 2024 (System Xc- ferroptosis in autism models): Ferroptosis via the System Xc-/GPX4 pathway is implicated in autism models, linking iron-dependent cell death to glutamate dysregulation. See research/Ferroptosis and Neuronal Iron
- Memantine RCT: 60.5% vs 8.3% for TTM (Grant 2023): Double-blind placebo-controlled study of memantine in 100 adults with TTM/skin-picking showed 60.5% improvement vs 8.3% placebo (NNT=1.9), providing strong confirmation of the glutamate hypothesis for BFRBs alongside the NAC evidence. See Trichotillomania and Neurodevelopmental Links
- Brancati 2025 ("Hidden phenotype"): Found that 21.9% of adults with ADHD screened positive for ASD, with higher age at first clinical referral, greater emotional dysregulation, more mood/anxiety comorbidity, and evening chronotype — describing the "hidden phenotype" of autism in adults diagnosed with ADHD. See Late-Diagnosed Autism - Distinct Profile
- No PubMed study exists on stimulant-mediated autism unmasking: Despite clinical recognition of this phenomenon, no peer-reviewed study has directly investigated stimulant medication unmasking autistic traits — this remains an evidence gap supported only by clinical observation and grey literature
- East et al. (infant iron deficiency predicts SCT/CDS): Infant iron deficiency predicted SCT/CDS symptoms in childhood and adolescence, establishing an early developmental link between iron status and cognitive disengagement. See ADHD-PI and Internal Hyperactivity
- Mitchell 2009 (H63D and glutamate): H63D HFE cells show directly increased glutamate release and reduced glutamate uptake capacity, demonstrating that Anthony's H63D variant may promote glutamate excitotoxicity — the same pathway implicated in trichotillomania and targeted by NAC. See Genetic Architecture of AuDHD
How to Use This Vault
- Start here for an overview, then follow wikilinks into topics
- Each note has a Cross-References section at the bottom linking to related notes
- Use Obsidian's Graph View to visualise connections between topics
- The Action Items and Monitoring Plan note contains practical next steps
- The research/Research Avenues Tracker tracks research leads and their status
- The Diet and Supplement Strategy note contains the supplement protocol
- Update Blood Results - March 2026 with future test results to track progress
Key Themes Across Notes
1. Iron Overload Cascade
Colour key: 🟣 Genetics | 🔴 Iron pathway / mechanism | 🟡 Symptom endpoint
flowchart TD
classDef gen fill:#d2b4de,stroke:#7d3c98,color:#1a0422
classDef iron fill:#f1948a,stroke:#c0392b,color:#1a0505
classDef out fill:#f7dc6f,stroke:#b7950b,color:#1a1400
A[HFE C282Y / H63D]:::gen --> B[Iron Overload]:::iron
B --> C[NTBI + Oxidative Stress]:::iron
B --> I[Brain Iron]:::iron
B --> N[Gut Dysbiosis]:::iron
C --> E[Fatigue + Joint Damage]:::out
C --> GSH[GSH Depletion]:::iron
GSH --> FPT[Ferroptosis]:::out
GSH --> GLU[Glutamate Excess]:::out
I --> ADHD[ADHD Symptoms]:::out
I --> TTM[Trichotillomania]:::out
I --> ASD[Autism Symptoms]:::out
N --> KYN[Kynurenine Shunt]:::iron
KYN --> TTM
KYN --> SLP[Poor Sleep]:::out
B --> TEST[Low Testosterone]:::out2. Sleep as Central Amplifier
Colour key: 🔵 Sleep mechanism | 🔴 Feeds back into iron/inflammation | 🟡 Symptom endpoint
flowchart TD
classDef sleep fill:#85c1e9,stroke:#2471a3,color:#0a1929
classDef out fill:#f7dc6f,stroke:#b7950b,color:#1a1400
classDef feed fill:#f1948a,stroke:#c0392b,color:#1a0505
R[Poor Sleep]:::sleep
R --> AH[Low Glymphatic Clearance]:::sleep
R --> AI[Gut Dysbiosis]:::sleep
R --> AJ[Low Executive Function]:::sleep
R --> AK[DA Downregulation]:::sleep
R --> AL[Sensory Amplification]:::sleep
R --> AM[High Cortisol]:::sleep
R --> FPT[Ferroptosis Acceleration]:::sleep
AH --> BI[Brain Iron]:::feed
AI --> IDO[IDO Activation]:::feed
AM --> IDO
AJ --> ADHD[ADHD Symptoms]:::out
AJ --> TTM[Trichotillomania]:::out
AK --> ADHD
AL --> ASD[Autism Symptoms]:::out
ADHD --> R
ASD --> R
MASK[Masking Cost]:::out --> R
HYP[Internal Hyperactivity]:::out --> R
ELV[Elvanse]:::out --> R
AL -.-> R3. Interventions and Targets
Colour key: 🟢 Intervention | 🟠 Medication | 🔴 Target / problem
flowchart LR
classDef protect fill:#58d68d,stroke:#1e8449,color:#0a1f12
classDef med fill:#f0b27a,stroke:#ca6f1e,color:#1a1000
classDef target fill:#f1948a,stroke:#c0392b,color:#1a0505
subgraph TREAT ["Treatment"]
M[Phlebotomy]:::protect
L[Diet Changes]:::protect
BA[Exercise]:::protect
BB[NAC]:::protect
AN[Melatonin]:::protect
AO[Chronotherapy]:::protect
AP[Sensory Optimisation]:::protect
end
subgraph MEDS ["Medication"]
J[Elvanse 70mg]:::med
end
%% Phlebotomy targets
M -.-> IO[Iron Overload]:::target
M -.-> PIT[Pituitary Iron]:::target
M -.-> TEST[Low Testosterone]:::target
%% Diet targets
L -.-> IO
%% Exercise targets
BA -.-> BI[Brain Iron]:::target
BA -.-> DA[DA Downregulation]:::target
BA -.-> SLP[Poor Sleep]:::target
BA -.-> GUT[Gut Dysbiosis]:::target
%% NAC targets
BB -.-> GSH[GSH Depletion]:::target
BB -.-> FPT[Ferroptosis]:::target
BB -.-> GLU[Glutamate Excess]:::target
BB -.-> TTM[Trichotillomania]:::target
%% Sleep interventions
AN -.-> SLP
AO -.-> SLP
AP -.-> SENS[Sensory Reactivity]:::target
%% Elvanse effects
J --> APP[Appetite Suppression]:::med
APP -.-> CUZN[Cu / Zn Depletion]:::target
J --> UNMASK[Autistic Unmasking]:::medCitation Summary
All notes contain inline citations. Key journals referenced:
- Nature, Nature Genetics (autism subtypes, GWAS)
- Blood, Hepatology, J Hepatol (haematology/hepatology)
- Arch Gen Psychiatry, JAMA Psychiatry (NAC for trichotillomania)
- Radiology, Eur Radiol (brain iron imaging)
- PLoS One, Sci Rep, BMC Genomics (general science)
- Molecules, Nutrients, Biol Trace Elem Res (mineral metabolism)
- Front Psychiatry, Front Microbiol, Dev Cogn Neurosci, Int J Mol Sci (neuropsychiatry, gut-brain)
- Gut Microbes, BMC Microbiol (microbiome)
- Mol Autism, Autism Research (autism-specific)
- J R Coll Physicians Edinb, JBMR Plus (musculoskeletal)
- EASL Guidelines, BJH Guidelines, GeneReviews (clinical guidelines)
Disclaimer: This research vault is for personal information-tracking purposes. It does not constitute medical advice. All clinical decisions should be made with qualified healthcare professionals.